Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jan 2;121(1):e2319797121.
doi: 10.1073/pnas.2319797121. Epub 2023 Dec 26.

Molecular chaos under the skin: Epigenetic reprogramming in hidradenitis suppurativa

Affiliations
Comment

Molecular chaos under the skin: Epigenetic reprogramming in hidradenitis suppurativa

Gagan Chhabra et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests statement:The authors declare no competing interest.

Figures

Fig. 1.
Fig. 1.
Epigenetic reprogramming in human skin inflammatory disorder HS. Compared to healthy skin, HS lesional epidermis is surrounded by heterogenous basal stem/progenitor cells with a significantly increased number of PTTG1+, HELLS+, and COL17A1+ cells favoring the recruitment of HS-associated immune cells. Stem cells lose their identity and differentiate to favor the formation of an epidermal cyst. HS-specific S100A+ keratinocyte cells amplify immune responses. After early inflammatory signals, substantial chromatin remodeling occurs in the genomic landscape of basal keratinocytes causing transcriptional activation of HS-associated genes to further drive recurrent inflammatory insults. The figure was created using Biorender.

Comment on

Similar articles

References

    1. Goldburg S. R., Strober B. E., Payette M. J., Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J. Am. Acad. Dermatol. 82, 1045–1058 (2020). - PubMed
    1. Shih T., et al. , Gender differences in hidradenitis suppurativa characteristics: A retrospective cohort analysis. Int. J. Womens Dermatol. 7, 672–674 (2021). - PMC - PubMed
    1. Vinkel C., Thomsen S. F., Hidradenitis suppurativa: Causes, features, and current treatments. J. Clin. Aesthet. Dermatol. 11, 17–23 (2018). - PMC - PubMed
    1. Smith S. D. B., Okoye G. A., Sokumbi O., Histopathology of hidradenitis suppurativa: A systematic review. Dermatopathol. (Basel). 9, 251–257 (2022). - PMC - PubMed
    1. Goldburg S. R., Strober B. E., Payette M. J., Hidradenitis suppurativa: Current and emerging treatments. J. Am. Acad. Dermatol. 82, 1061–1082 (2020). - PubMed